Eikon Therapeutics, Inc. (EIKN) stock
EIKNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$5.17+0.02 (+0.39%)
Close on Nov 18, 2026Market cap $280.03MP/E –Yield –
Eikon Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Eikon Therapeutics's market cap was $361.17M on Nov 11, 2026.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $361.17M | – |
See a number that looks wrong?